ABBOTT PARK, Ill., April 20 /PRNewswire-FirstCall/ -- Abbott today announced that it has received antitrust clearance from the U.S. Federal Trade Commission relating to its proposed acquisition of Guidant’s vascular business. The company received European Commission clearance for the transaction on Tuesday, April 11. Abbott anticipates closing the transaction on Friday, April 21.
About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 60,000 people and markets its products in more than 130 countries.
Abbott’s news releases and other information are available on the company’s Web site at http://www.abbott.com .
Abbott
CONTACT: Media, Melissa Brotz, +1-847-935-3456, or Jonathon Hamilton,+1-847-935-8646, or Financial Community, John Thomas, +1-847-938-2655, orTina Ventura, +1-847-935-9390, all of Abbott
Web site: http://www.abbott.com/
Company News On-Call: http://www.prnewswire.com/comp/121546.html /
